MAPT and Alzheimer disease: One of the most effective EGCG analogs that we discovered in our screen, CNS-11, is calculated to interact with AD-tau by many of the same hydrogen-bonding interactions as EGCG, including potential interactions with Lys340 and Glu342 (Fig. 3g).